MYIA
RXDX

Mount Yale Investment Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Mount Yale Investment Advisors’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,266
Closed -$243K – 518
2023
Q1 		$243K Sell
2,266
-17
-0.7% -$1.82K 0.03% 427
2022
Q4 		$251K Buy
+2,283
New +$251K 0.03% 386